about
PCQoL: A Quality of Life Assessment Measure for Pachyonychia Congenita.Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy.Acne, depression, and suicide.Management of acne: Canadian clinical practice guideline.Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenita.HLA-DQB1*02 and DQB1*06:03P are associated with peanut allergy.Extracorporeal photopheresis for the treatment of Crohn's disease.Clinicopathologic, immunophenotypic, and molecular characterization of primary cutaneous follicular B-cell lymphoma.A Case of Lichen Sclerosus et Atrophicus With Distinct Erythematous Borders.Decreasing Rates of Neomycin Sensitization in Western Canada.Duplicated Enhancer Region Increases Expression of CTSB and Segregates with Keratolytic Winter Erythema in South African and Norwegian Families.Hyposensitization and desensitization in allergic contact dermatitis.Atrophying pityriasis versicolor.Treatment of cutaneous sporotrichosis with terbinafine.Filaggrin gene mutation associations with peanut allergy persist despite variations in peanut allergy diagnostic criteria or asthma statusFilaggrin null alleles are not associated with psoriasis.Transgrediens pachyonychia congenita (PC): case series of a nonclassical PC presentation.Chronic Spontaneous Urticaria – the Saskatchewan experience and questionnaire survey.Chronic Spontaneous Urticaria – an evaluation of an indirect immunofluorescence method for detecting anti-mast cell IgG antibodies.The elusive gene for keratolytic winter erythema.Prevalence, epidemiology and geographical distribution of Sporothrix schenckii infections in Gauteng, South Africa.Exclusion of CTSB and FDFT1 as positional and functional candidate genes for keratolytic winter erythema (KWE).Chronic Spontaneous Urticaria: A Questionnaire Survey.Indirect Immunofluorescence for the Detection of Autoimmune Urticaria.Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczemaNull Mutations in the Filaggrin Gene (FLG) Determine Major Susceptibility to Early-Onset Atopic Dermatitis that Persists into AdulthoodHeterozygous Null Alleles in Filaggrin Contribute to Clinical Dry Skin in Young Adults and the ElderlyRecessive mutations in the gene encoding frizzled 6 cause twenty nail dystrophy—Expanding the differential diagnosis for pachyonychia congenitaA Large Mutational Study in Pachyonychia CongenitaBreach Delivery: Increased Solute Uptake Points to a Defective Skin Barrier in Atopic DermatitisActinic chickenpox. Light-distributed varicella eruptionPeri-umbilical cutaneous schistosomiasis: A case reportThe melanocyte: an essential link in hydroquinone-induced ochronosisEruptive tumors on sun-exposed skin after benoxaprofenAcute hereditary coproporphyria induced by the androgenic/anabolic steroid methandrostenolone (Dianabol)Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trialMycosis fungoides and chronic lymphocytic leukaemia--composite T-cell and B-cell lymphomas presenting in the skinOnychomycosis: an evaluation of three sampling methodsTrends in invasive cutaneous melanoma in Saskatchewan 1970-1999Angiosarcoma-like presentation of pacemaker-related vascular proliferation
P50
Q34467382-5825C790-5DD4-454F-9057-A0389DBB89A9Q34837055-B4750343-6F6C-4A2F-A30A-1B31A756A208Q36236247-4A3B4B2D-4C4C-4741-B00F-0957610DBB4AQ36520694-C7866B8D-4C28-44B5-A3F1-2513D832160EQ37169944-51209E93-E784-40CB-BC7B-2A488D14A13CQ37186022-6A15FB4F-D3AF-4EDA-B988-158BF855CB60Q38369663-A20F6E9B-90EA-40A3-9F63-FD9AAF8EEA8EQ38461514-3122DC39-E8DF-4363-AA1B-2C7FD48145BCQ38520809-3E22DE43-58AC-45C2-8AB3-0AAD20C49738Q38678126-435FFFD5-3513-424B-8FA9-C90239CE48E1Q38812306-98C82580-8C80-40B5-9180-AD7BD44AB413Q39580527-156C38A1-974D-48B3-87A6-F51ADAB67E61Q41791431-0BEF370C-D485-48BD-A6A2-E572820F02ACQ41863966-BA28723F-FF47-4586-AB61-0795950C365BQ42550090-E81DD7B5-A4A3-4938-A435-8EDC812A4960Q42616409-FA3B4E1C-3670-4796-902F-72B2CFBF77D2Q44342114-DA6C8AED-14A0-444F-8F6B-6209C29983B3Q46043037-82CA54DC-95F1-4F27-95B5-9B2BEEC1E746Q46043490-5D0F9288-2279-43E8-81D1-DB5B832D19B2Q46181865-DF2B9AF0-909F-49BD-8364-2F372838E7CAQ46591012-BDAF0CD8-2323-4C82-B5FF-3B608A197083Q46941358-14DFFB88-ABA0-4FF3-99FA-A8261C15C11CQ47607803-41740AD1-725C-45D5-A989-D097BD782F5AQ52911039-A73DCEBF-DAF2-41A2-AD5D-2AEB3C2E29FDQ57061506-97E99641-D9F4-4381-BD8F-D9280AB64055Q57149033-A8B72525-AFCA-4DDE-B94D-482C92B0A58FQ57638950-D61E3029-276C-4E5D-85A0-8B60855DA0D2Q58859485-4E204463-9A22-4ABD-8A02-5E6D793AB5A4Q58859581-E7A47D9B-3021-4E4E-9C13-62015D9BDB83Q58859839-5BBE4097-B54A-46ED-BEC4-8F0C03E17440Q66917195-D612EC1A-EAD1-44DA-9909-9627BE3F47CCQ67006099-F956D9D9-1C13-47BC-BBAC-EFEB3A7B6167Q68727182-AE482E68-C7E6-4912-B56C-DBCE57D5367EQ72528529-D9C4F2D6-D638-420D-AAA1-39C459F6C0E2Q72740378-F3923594-2F05-471F-966B-2282A8813A5DQ73874830-B7D416FC-3341-4C7E-BB4E-3D6789FE1FBCQ74198792-24269DCC-4C85-4B47-8A0F-912B5EE404D6Q77647313-FD309379-9211-4B71-8EB6-A885483F66CAQ81799915-4EC8C071-6C88-4FFB-B0BA-7201930EA0F9Q82627534-EA7EA6FB-792C-4456-B6B5-7539ECF4C034
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Peter R Hull
@ast
Peter R Hull
@en
Peter R Hull
@es
Peter R Hull
@nl
type
label
Peter R Hull
@ast
Peter R Hull
@en
Peter R Hull
@es
Peter R Hull
@nl
prefLabel
Peter R Hull
@ast
Peter R Hull
@en
Peter R Hull
@es
Peter R Hull
@nl
P106
P31
P496
0000-0002-3896-9373